Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: J Pediatr Hematol Oncol. 2016 Aug;38(6):449–452. doi: 10.1097/MPH.0000000000000606

Figure 1. MTX clearance and 42 hr exposure subdivided by risk group and TMP/SMX status.

Figure 1

Figure 1

(A) Boxplot of individual methotrexate clearance estimates subdivided by risk group and TMP/SMX status. The bar, box, and whiskers represent the median, 25th–75th percentile, and non-outlier range respectively. n is the number of courses in each group. (B) Boxplot of individual methotrexate 42 hour plasma concentration subdivided by risk group and TMP/SMX status. The bar, box, and whiskers represent the median, 25th-75th percentile, and non-outlier range respectively. n is the number of courses in each group.